We are truly happy and fortunate to welcome Drs. Christine Tardif and David Rudko as new BIC core Faculty members, effective May 01, 2017. They join the BIC team and platform as MR specialists, in particular at ultra-high fields for small-animal and human imaging.

Classified as: BIC
Published on: 2 May 2017

The Montreal Neurological Institute and Hospital (The Neuro) is home to Canada’s first multiple sclerosis (MS) clinic, and MS research and treatment has been a major focus at The Neuro for many years. The MS clinic employs a highly specialized staff who have access to the latest research data and methods of treatment. It is a clinic where innovation and progress are paramount.

Classified as: Multiple Sclerosis, MNI; medicine research; faculty of medicine
Published on: 1 May 2017

Brain diseases and disorders are the leading cause of disability, directly affecting one in three Canadians as well as millions of family members, friends, colleagues and caregivers. The Government of Canada recognizes the significant impact on the health of Canadians, and supports Canadian research on the brain and related diseases and disorders

Classified as: autism, Alan Evans, brain imaging, Sylvain Baillet, Brain Canada, McConnell Brain Imaging Centre, Canada Brain Research Fund
Published on: 27 Apr 2017

It is our great pleasure to announce that our centre has been awarded a Brain Canada Platform Support Grant of $3.9M. We are thankful to the MNI and the Webster Family Foundation for providing the matching funds that have been key to secure this funding. The PSG grant is to add capacity for data acquisition, management, analytics, dissemination, with an emphasis on open-access sharing, expanding capacity for all imaging modalities featured at the BIC, and training of staff, highly-qualified personnel and platform users over 3 years. 

Classified as: BIC
Published on: 27 Apr 2017

Multidisciplinary care and cutting-edge research share space at The Neuro

The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.

Classified as: Neuro, Montreal Neurological Institute and Hospital, medicine research, MNI; Faculty of Medicine
Published on: 1 Apr 2017

Discovery expands our understanding of how we remember sound

The ability to remember sounds, and manipulate them in our minds, is incredibly important to our daily lives — without it we would not be able to understand a sentence, or do simple arithmetic. New research is shedding light on how sound memory works in the brain, and is even demonstrating a means to improve it.

Classified as: Montreal Neurological Institute, Neurocognition, Neuroimaging and Neuroinformatics
Published on: 27 Mar 2017

March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide

The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the “Montreal Procedure” developed by The Neuro’s founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.

Classified as: neuroscience, brain, epilepsy, Neuro, Montreal Neurological Institute and Hospital, mcgill faculty of medicine research
Published on: 26 Mar 2017

Deep learning transforming neuroscience research

In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute’s McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.

Classified as: MNI, autism, Neuro, Sylvain Baillet, BIC, neuroimaging, brain imaging centre, deep learning
Published on: 20 Mar 2017

Montreal, Quebec and Vancouver, British Columbia – Working together to accelerate research into neurological diseases, three leading players in Canada’s health sciences sector are joining forces in a unique multi-million dollar partnership to create a novel drug development platform that will help advance new therapeutics for some of the most debilitating conditions such as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and Parkinson’s disease.

Classified as: Parkinson's, Merck, drug development, CDRD
Published on: 16 Mar 2017

The latest issue of Nature Neuroscience presents a special issue focused on the state of the art of human brain imaging. 

Classified as: BIC
Published on: 15 Mar 2017

Discovery could be key to treating brain and spinal cord injury

A foray into plant biology led one researcher to discover that a natural molecule can repair axons, the thread-like projections that carry electrical signals between cells. Axonal damage is the major culprit underlying disability in conditions such as spinal cord injury and stroke.

Classified as: MNI, Neuro, Neurology, stroke, spinal cord injury, axon repair, 14-3-3, Fusicoccin-A
Published on: 8 Mar 2017

Research and clinical care complement each other at The Neuro

February 28th was Rare Diseases Day, an opportunity to recognize a class of disease that is often overlooked. In the past five years, the Montreal Neurological Institute and Hospital (The Neuro) has made the study and treatment of rare diseases a major priority, hiring new specialists and support staff and coordinating activity under a new research group.

Classified as: genetics, Rare disases, Bernard Brais, Eric Shoubridge, ataxia
Published on: 28 Feb 2017

The BIC hosted a series of Deep Learning workshops organized by Santiago Paiva (Hoge lab) and Dr. Robert Brown (Arnold lab) on January 19th and 26th. 

Classified as: BIC
Published on: 6 Feb 2017

We are pleased to welcome Dr. Stephan Blinder as the new BIC PET physicist on staff. 
Stephan completed his PhD in Astrophysics (U de Bordeaux I, France) and later shifted his interest towards biomedical imaging research. He worked for 4 years with the MIRG group led by Dr. Anna Celler (U of British Columbia, Vancouver) on SPECT imaging, focusing on 3D and 4D image reconstruction techniques. 

Classified as: BIC
Published on: 6 Feb 2017

CQDM and Brain Canada join forces again in the funding of two new research projects to address unmet needs in brain research

CQDM and Brain Canada are proud to announce the funding of two new multi-disciplinary and multi-institutional research projects under the second edition of their Focus on Brain strategic initiative. The partners will award a total of $3M to two research teams to develop cutting-edge tools, technologies and platforms designed to accelerate the discovery of new drugs for brain and nervous system disorders.

Classified as: Parkinson's, Ted Fon, ALS, Brain Canada, Canada Brain Research Fund, CQDM, Fon, Edward Fon
Published on: 2 Feb 2017